
Research health scientist | EM pharmacist 🚑 | co-founder @EMPHARM_NET | inaugural president of @SAEM_AEMP |wife | boy mama 👦 👦
Denver, CO
Joined April 2017
- Tweets3.3K
- Following1.6K
- Followers5.4K
- Likes13.6K
Pinned Tweet
🚨 @ACEPNation ED Accreditation Criteria are out and thanks to @SAEMonline & @SAEM_AEMP a pharmacist is now required for all Level 1 & Level 2 sites - THIS is the work we're doing to advance EM pharmacy practice 👐acep.org/siteassets/sites/ed…
Megan Rech, PharmD, MS retweeted
September is Sickle Cell Awareness Month!🩸Swipe for key pharmacotherapy considerations for ED management of vaso-occlusive crisis.
Check out ACEP's EDSC3 resource page: buff.ly/uQyhMbY
Megan Rech, PharmD, MS retweeted
Skin and soft tissues infections are common conditions, affecting millions worldwide.
What's an evidence-based approach to diagnosis and management? #MedEd
bmj.com/content/394/bmj-2026…
Check out our @bmj_latest review on advances in diagnosis and management of skin and soft tissue infections 👇
Skin and soft tissues infections are common conditions, affecting millions worldwide.
What's an evidence-based approach to diagnosis and management? #MedEd
bmj.com/content/394/bmj-2026…
Megan Rech, PharmD, MS retweeted
September is Reye's Syndrome Awareness Month. Don't miss this rare, but preventable pediatric emergency! 🧠🦠💊
#SAEM #AEMP #ReyesSyndromeAwareness
Megan Rech, PharmD, MS retweeted
高K血症に関するreview。まとまってて勉強になった。どの患者群にロケルマが良いのか、GIの比率は?などは救急医としてこれからより気になっているところだなぁ。
bmj.com/content/394/bmj-2026…
Megan Rech, PharmD, MS retweeted
Hyperkalaemia is a common and potentially life threatening electrolyte abnormality.
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management #MedEd
bmj.com/content/394/bmj-2026…
Megan Rech, PharmD, MS retweeted
Diagnosis and management of acute hyperkalaemia - 🆕 2026 BMJ review 🔢
1️⃣ Potassium homeostasis ⚙️
2️⃣ Causes and risk factors 💡
3️⃣ Management 🚨
4️⃣ Drug treatments 💊
🆓: bmj.com/content/bmj/394/bmj-…
Megan Rech, PharmD, MS retweeted
Listen now: emrap.org/episode/overhyped/…
Megan Rech, PharmD, MS retweeted
Are you using droperidol or haloperidol to manage patients with cannabinoid hyperemesis syndrome (CHS)?
Comment below what your current front line treatment is. 💭
There are a few new directions you can go and a few things you should avoid in these patients. @EMSwami and Megan will give you the rundown, and discuss a few novel therapies as well.
#CHS #cannabinoidhyperemisissyndrome #MedEd #emergencymedicine
Megan Rech, PharmD, MS retweeted
高K血症のわかりやすい総説がBMJから出ています。
Ca製剤の機序が「Restoration of cardiac conduction」とされていたり、SZC(ロケルマ)について記載されていたり、実はいろいろとアップデートされている領域です。
Na異常に比べると研究はしやすいと思います。
bmj.com/content/394/bmj-2026…
Megan Rech, PharmD, MS retweeted
Nueva revisión de hiperkalemia aguda (BMJ 2026). Lo que cambió, y que probablemente sigas haciendo:
🔴 Dextrosa al 10%, no al 50%. La glucosada hipertónica puede EMPEORAR la hiperkalemia.
🔴 Insulina 5 U (o 0.1 U/kg, máximo 10 U). Misma caída de potasio que con 10 U, con casi la mitad de hipoglucemias (OR 0.55).
🔴 1 g de gluconato de calcio no sirve. 97% necesitó tres dosis de 1 g y una sola dosis no funcionó en NINGUNO. Dosis: 1-3 g.
🔴 El calcio no "estabiliza la membrana". Restaura la conducción por canales de calcio. Traducción práctica: sirve cuando hay QRS ancho, no en la onda T picuda aislada.
🔴 Bicarbonato: no se recomienda de rutina.
🔴 La onda T picuda aparece en menos del 25% de los pacientes con K de 5.5-7.0. Un ECG normal NO descarta hiperkalemia.
🔴 Reevalúa el potasio a los 60 min y otra vez a las 2-4 horas. El rebote es frecuente
El tema ya está re-escrito y actualizado en Memodi y Accio. Completo en el canal (t.me/memodiapparticulos).
Megan Rech, PharmD, MS retweeted
Hyperkalaemia is a common and potentially life threatening electrolyte abnormality.
This state of the art review summarises data on the epidemiology, identifies key risk factors and diagnostic considerations, and reviews approaches to management
bmj.com/content/394/bmj-2026…
Very excited to share our State of the Art review entitled Diagnosis and Management of Acute Hyperkalaemia published in @bmj_latest
✅Check it out for a nice overview of the epidemiology and pathophysiology of hyperkalaemia, key risk factors and diagnostic considerations, and evidence based approaches to acute management
bmj.com/content/394/bmj-2026…
@LRayRx @DEZ_EM_Pharm @DharatiDesai @gavin_howington @MileHighEMCCM
Megan Rech, PharmD, MS retweeted
New consensus statement 🧠🚑
Pharmacist involvement cut stroke door-to-needle time by 15+ min and hemorrhagic reversal time by up to 75 min.
Proud to be part of this statement endorsed by @ACCP, @SAEMonline, @SCCM, @neurocritical, @AANmember.
#EMPharmD
accpjournals.onlinelibrary.w…
Megan Rech, PharmD, MS retweeted
📣 Check out the latest @EMPHARM_NET study of 362 adults with TBI or sICH at 11 US EDs who received sugammadex
📈 A positive response (⬆️GCS ≥1) was seen in 54% & associated with a new analgesia, sedation & non-significant⬆️neurosurgical procedures
👉sciencedirect.com/science/ar…
Megan Rech, PharmD, MS retweeted
Excited to share that @PharmD_Jamie and I published the first article in the new recurring #AEMPAskthePharmacist column in @EMNews: “Laughing Gas, Serious Consequences,” on nitrous oxide toxicity in the ED.
ovid.com/10.1097/01.EEM.0000…
#EMPharmD #clintox @SAEM_AEMP @SAEMonline
Megan Rech, PharmD, MS retweeted
Everyone please welcome our incoming Committee Chairs! As you see, we'we're continuing to grow & have expanded committees this year! Please reach out to any of our chairs with questions or interest in committee involvement! #AEMP #AEMPlify #pharmacyleaders #welcome #EMRx






































